Home > Healthcare > Biologic Excipients Market
Biologic Excipients Market Size
Biologic Excipients Market registered substantial expansion in 2023 and will record notable CAGR during 2024 and 2032, owing to the ongoing advancement of innovative biologic formulations. As the pharmaceutical industry continues to evolve, the demand for excipients that enhance the stability, delivery, and efficacy of biopharmaceuticals grows. This trend propels excipient manufacturers to develop specialized solutions, contributing to the dynamic growth of the market and addressing the evolving needs of the biopharmaceutical sector.
For instance, in May 2023, Roquette introduced PEARLITOL® ProTec, a novel excipient designed to enhance the stability of probiotic supplements. This plant-based co-processed blend of mannitol and maize starch safeguards moisture-sensitive active ingredients, such as probiotics, ensuring prolonged shelf life, consistent quality, and expanded possibilities for consumer-friendly dosage formats.
The surge in demand for biopharmaceuticals is a key catalyst driving the growth of the biologic excipients market. The industry is further stimulated by recent product launches that cater to evolving pharmaceutical needs. As the industry focuses on developing advanced excipients to enhance the efficacy and stability of biologic formulations, this synergy between increasing demand and continuous product innovation will position the industry for sustained growth and expansion.
For instance, in November 2023, Roquette, a company specializing in plant-based ingredients and supplying pharmaceutical and nutraceutical excipients, expanded its portfolio by introducing three new excipient grades. These additions enhance the range of solutions available for moisture-sensitive active pharmaceutical and nutraceutical ingredients.
However, the growth of biologic excipients faces challenges such as stringent regulatory requirements and the intricate nature of biologic formulations. These challenges underscore the commitment to ensuring safety, efficacy, and quality standards in the development of excipients for biopharmaceuticals. Navigating these complexities presents opportunities for innovation, encouraging industry players to develop specialized and high-quality excipients that align with evolving regulatory standards and address the unique needs of biologic formulations.
Biologic Excipients Market Trends
The biologic excipients industry is significantly propelled by the trend toward developing multifunctional excipients. With a growing emphasis on enhancing the performance and efficacy of biopharmaceutical formulations, the industry is focusing on excipients that serve multiple functions. This trend ensures improved stability, targeted delivery, and overall optimization of biologic drugs. As pharmaceutical manufacturers seek more efficient and versatile solutions, the emphasis on multifunctional excipients continues to drive innovation and growth in the industry.
For instance, in October 2023, Clariant, a sustainability-oriented specialty chemicals firm, introduced a range of excipients to enhance its pharmaceutical solutions. The three new VitiPure® excipients cater to various Active Pharmaceutical Ingredient (API) formulations, supporting the development of safe and effective medicines, including applications for sensitive drugs like mRNA vaccines and biologics.
Biologic Excipients Market Analysis
The inorganic product segment will secure a remarkable market share by 2032 due to the versatile applications of inorganic excipients in the formulation of biologic drugs. Inorganic excipients play a critical role in enhancing stability and functionality in various biopharmaceutical formulations. The increased focus on optimizing drug performance and ensuring regulatory compliance further supports the growth of the inorganic product segment, solidifying its position as a primary driver in the biologic excipients industry.
The topical formulation will establish a significant biologic excipients market foothold from 2024 to 2032, driven by the increasing demand for biologic drugs in dermatology and transdermal applications. Topical formulations offer localized drug delivery, making them a preferred choice for conditions such as skin disorders and pain management. The versatility and patient-friendly nature of these formulations contribute to their dominance. As the prevalence of dermatological conditions rises, the topical formulation segment will maintain its leading position in the market.
Asia Pacific biologic excipients market will demonstrate a noteworthy CAGR from 2024 to 2032, attributed to the increasing adoption of biopharmaceuticals and the rapid growth of the pharmaceutical industry in the region. Rising healthcare expenditures, an expanding patient population, and a supportive regulatory environment contribute to the region's prominence. As pharmaceutical manufacturing capabilities strengthen, key players are strategically focusing on the Asia Pacific market, solidifying its position as a pivotal contributor to the biologic excipients industry.
Biologic Excipients Market Share
- Kerry Group PLC
- Colorcon Inc. (BPSI Holdings)
- Evonik Industries AG (Rag-Stiftung)
- Roquette Frères
- Ashland
- Croda International
- Dupont De Nemours, Inc.
- BASF SE
- Meggle USA
Companies are strategically advancing their market share through innovative strategies and capitalizing on market dynamics. Given the rising demand for biopharmaceuticals, excipients are pivotal for enhancing the stability, formulation, and delivery of biologic drugs. Industry leaders are allocating substantial investments in research and development to introduce advanced excipients that effectively address specific challenges associated with biologic formulations, reinforcing their position in this evolving sector of the pharmaceutical industry.
Collaborations with pharmaceutical manufacturers and biotech firms further amplify biologic excipients market penetration, enabling them to offer comprehensive solutions for diverse biologic drug development needs. Moreover, a focus on regulatory compliance and the development of excipients with improved safety profiles positions these companies as preferred partners in the evolving biopharmaceutical landscape. Through a combination of technological advancements, strategic partnerships, and a commitment to meeting industry demands, these players are driving substantial growth in the competitive biologic excipients industry.
Biologic Excipients Industry News
In September 2023, Colorcon introduced an innovative moisture protection coating for pharmaceutical tablets, eliminating titanium dioxide. This launch signifies a step forward in tablet formulation, addressing both aesthetic and functional considerations.
In January 2024, Performance Lab unveiled a new collection of individual nutrients featuring nine supplements as part of the NutriGenesis line, offering a comprehensive range of vitamins and minerals for optimal health support.